December Private Market Update
Forge Price 1 updated December 21, 2024omadahealth.comHealthcare / Digital HealthFounded: 2011Funding to Date: $919.75MM
Omada Health, founded in 2011, is a digital health company that aims to help individuals achieve their wellness objectives by fostering long-lasting lifestyle modifications. The company offers a comprehensive digital care program, which provides personalized support and guidance seeking to empower users in taking charge of their health and well-being. Omada Health is headquartered in San Francisco, California.
| Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
|---|---|---|---|---|---|---|
| 02/23/2022 | Series E | $192MM | $xx.xx | $1.02B | Amoon, Civilization Ventures, Fidelity, Perceptive Advisors, Wellington Management | |
|
Price per Share
$xx.xx
Shares Outstanding
32,025,620
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amoon, Civilization Ventures, Fidelity, Perceptive Advisors, Wellington Management
|
||||||
| 03/16/2021 | Series D-1 | $27MM | $xx.xx | $780.77MM | Undisclosed Investors | |
|
Price per Share
$xx.xx
Shares Outstanding
4,503,601
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
| 05/19/2020 | Series D | $112.47MM | $xx.xx | $612.85MM | Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Perceptive Advisors, Providence Ventures, Sanofi-Genzyme Bioventures, Us Venture Partners, Wellington Management | |
|
Price per Share
$xx.xx
Shares Outstanding
22,330,212
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Perceptive Advisors, Providence Ventures, Sanofi-Genzyme Bioventures, Us Venture Partners, Wellington Management
|
||||||
| 05/10/2017 | Series C-1 | $49.99MM | $xx.xx | $320.25MM | Andreessen Horowitz, Cigna, Civilization Ventures, Drx Capital, Ge Ventures, Humana, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi Genzyme Bioventures, U.S. Venture Partners | |
|
Price per Share
$xx.xx
Shares Outstanding
13,357,797
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Cigna, Civilization Ventures, Drx Capital, Ge Ventures, Humana, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi Genzyme Bioventures, U.S. Venture Partners
|
||||||
| 10/01/2015 | Series C | $48.67MM | $xx.xx | $216.43MM | Andreessen Horowitz, Designer Fund, Drx Capital, Ge Ventures, Humana Ventures, Ideo Futures, Norwest Venture Partners, Providence Ventures, Rock Health, Us Venture Partners | |
|
Price per Share
$xx.xx
Shares Outstanding
15,385,707
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Designer Fund, Drx Capital, Ge Ventures, Humana Ventures, Ideo Futures, Norwest Venture Partners, Providence Ventures, Rock Health, Us Venture Partners
|
||||||
| 04/09/2014 | Series B | $23.33MM | $xx.xx | $60.57MM | Andreessen Horowitz, Kaiser Permanente Ventures, The Vertical Group, U.S. Venture Partners | |
|
Price per Share
$xx.xx
Shares Outstanding
19,724,378
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Kaiser Permanente Ventures, The Vertical Group, U.S. Venture Partners
|
||||||
| 03/21/2013 | Series A | $6.43MM | $xx.xx | $16.11MM | Founder Collective, Healthtech Capital, Kapor Capital, New Enterprise Associates, The Vertical Group, Triplepoint Capital, U.S. Venture Partners | |
|
Price per Share
$xx.xx
Shares Outstanding
12,027,426
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Founder Collective, Healthtech Capital, Kapor Capital, New Enterprise Associates, The Vertical Group, Triplepoint Capital, U.S. Venture Partners
|
||||||
To invest in a private company like Omada Health through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
If you hold private company shares of Omada Health – whether as an employee or an early investor – Forge can help you sell them.
The majority of Americans live with chronic conditions — like diabetes and arthritis — and 90% of healthcare spending in the U.S. goes toward chronic and mental health conditions, according to data sourced by the CDC.
